l-lysine methyl ester has been researched along with thioctic acid in 1 studies
| Studies (l-lysine methyl ester) | Trials (l-lysine methyl ester) | Recent Studies (post-2010) (l-lysine methyl ester) | Studies (thioctic acid) | Trials (thioctic acid) | Recent Studies (post-2010) (thioctic acid) |
|---|---|---|---|---|---|
| 8 | 0 | 3 | 4,628 | 322 | 1,947 |
| Protein | Taxonomy | l-lysine methyl ester (IC50) | thioctic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 2.68 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 2.68 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 0.2008 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 2.68 | |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | 16.56 | |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | 16.56 | |
| Vif | Human immunodeficiency virus 1 | 7.67 | |
| Tat | Human immunodeficiency virus 1 | 5.891 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 7.67 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, R; Deng, C; Meng, F; Xie, F; Zhang, J; Zhong, Y; Zhong, Z | 1 |
1 other study(ies) available for l-lysine methyl ester and thioctic acid
| Article | Year |
|---|---|
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Chemistry, Pharmaceutical; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Injections, Intravenous; Lysine; MCF-7 Cells; Mice, Nude; Molecular Targeted Therapy; Nanomedicine; Nanoparticles; Solubility; Technology, Pharmaceutical; Thioctic Acid; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |